Mar 6 |
Kamada Issues 2024 CEO Letter to Shareholders
|
Mar 6 |
Kamada Reports Strong Fiscal Year and Fourth Quarter 2023 Financial Results, and Provides Full-Year 2024 Guidance Representing Double-Digit Growth in Revenue and Profitability
|
Mar 5 |
Kamada Q4 2023 Earnings Preview
|
Feb 28 |
Kamada to Announce Fourth Quarter and Fiscal Year 2023 Financial Results, and Provide 2024 Financial Guidance on March 6, 2024
|
Dec 8 |
Kamada: Kedrion Deal Locks In Growth
|
Dec 7 |
KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB®
|
Dec 7 |
KMDA: Amendment and Extension of Kedrab® U.S. Distribution Agreement to Generate at Least $180 Million Over First Four Years…
|
Dec 6 |
Kamada extends commercial deal for U.S. distribution; sees $180M rev over first four years
|
Dec 6 |
Kamada Announces its Largest Commercial Agreement; A Strategic Engagement with Kedrion for U.S. Distribution of KEDRAB® including $180 Million of Revenues Over First Four Years
|
Nov 21 |
Kamada: Solid Specialty Plasma Play
|